Loading financial data...

Drugs Made In America Acquisition Corp. (DMAA) Financial Statements | Global Financial Data

Drugs Made In America Acquisition Corp.

DMAASEC EDGAR

Blank ChecksCIK: 2028614

Concept	FY2024
Net Income (Loss) Attributable to Parent	-$279.8K
Earnings Per Share, Basic	-$0.03
Earnings Per Share, Diluted	-$0.03

Concept	FY2024
Assets	$550.8K
Assets, Current	$5.0K
Liabilities	$795.7K
Stockholders' Equity Attributable to Parent	-$244.8K
Common Stock, Shares, Outstanding	$9.9M

Concept	FY2024
Net Cash Provided by (Used in) Operating Activities	-$172.3K
Net Cash Provided by (Used in) Financing Activities	$173.6K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)